Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Drug Discovery Outsourcing Market From 2025 To 2029?
In recent times, the drug discovery outsourcing market has witnessed robust growth. The market size is anticipated to expand from $3.92 billion in 2024 to $4.24 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.1%. The historical growth is attributed to factors including increasing complexity in drug discovery, a growing need for specialized knowledge, strict regulatory standards, a global expansion of clinical trials, and a rising demand for orphan drugs and personalized healthcare treatments.
What Is the Projected Market Size of the Drug Discovery Outsourcing Market?
In the coming years, the drug discovery outsourcing market is set to witness substantial growth, projected to reach $5.72 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 7.8%. This growth over the forecasted period can be linked to a rise in research and development costs, patent expirations, the growth of the biopharmaceutical industry, focus on core competencies, and the necessity to reduce the time-to-market. Key trends taking place during this prediction period include the implementation of artificial intelligence, advancements in technology, the use of big data analytics, the development of specialty drugs, and strategic collaborations and partnerships.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19405&type=smp
Who are the Major Competitors in the Drug Discovery Outsourcing Market Outlook?
Major companies operating in the drug discovery outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins SE, Charles River Laboratories, QIAGEN N.V., Curia Global Inc., EVOTEC, Pharmaron Beijing Co. Ltd., Genscript Biotech, WuXi AppTec, Pharmaceutical Product Development, LLC, Syngene International Limited, Jubilant Biosys, Dalton Pharma Services, Oncodesign Services, DiscoverX Corp., Domainex Ltd., Exscientia, TCG Lifesciences Pvt Ltd., GVK Biosciences Private Limited
What Is Fueling Growth in the Drug Discovery Outsourcing Market?
The increasing rates of chronic illnesses are anticipated to fuel the expansion of the drug discovery outsourcing market. Chronic illnesses refer to sustained health conditions that last for prolonged periods, often years or a lifetime. These illnesses are surging due to varied reasons such as an aging populace, lifestyle decisions, urbanization, and environmental conditions. Outsourcing drug discovery enhances the pace of treatment development for such diseases by offering specialized skills and cutting-edge technologies, thus lessening time and financial implications. For instance, the Australian Institute of Health and Welfare reported in June 2024 that approximately 15.4 million people, or 61% of the population, were suffering from at least one long-term health condition, consequently resulting in 90% of deaths in 2022. Among individuals aged 0–24, anxiety was found in 1.3 million (16%). Back problems were common in 1.5 million (23%) of those aged 45–64. Simultaneously, deafness or hearing loss affected 1.3 million (32%) of the population aged 65 and older. Therefore, the escalating prevalence of chronic diseases is facilitating the growth of the drug discovery outsourcing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19405&type=smp
Which Drug Discovery Outsourcing Market Segments Are Growing the Fastest?
The drug discovery outsourcingmarket covered in this report is segmented –
1) By Service Type: Chemistry Services, Biological Services
2) By Workflow: Target Identification And Screening, Target Validation And Functional Informatics, Lead Identification And Candidate Optimization, Preclinical Development, Other Workflows
3) By Disease Model: In Vitro Models, Animal Models, Cellular Models, Other Disease Models
4) By Therapeutic Area: Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Hematology, Respiratory System, Infectious Disease, Oncology, Immunology, Other Therapeutic Areas
5) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users
Subsegments:
1) By Chemistry Services: Custom Synthesis And Manufacturing, Medicinal Chemistry, Combinatorial Chemistry, Hit Identification And Lead Optimization, Process Chemistry And Scale-Up, Analytical Chemistry Services, Chemical Library Design And Screening, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling
2) By Biological Services: Cell-Based Assays And Screening, Target Identification And Validation, In Vitro And In Vivo Testing, Biomarker Discovery And Development, Toxicology Studies, Genomics And Proteomics Services, Animal Models For Preclinical Development, Biological Safety And Efficacy Testing, Biopharmaceutical Development And Manufacturing.
Which Industry Trends Are Shaping the Future of the Drug Discovery Outsourcing Market?
Prominent enterprises in the drug discovery outsourcing market are concentrating on fostering technological advancements, such as digital health solutions, to better cater to the requirements of healthcare experts, regulators, and patients. These digital health solutions include technologies and services like telemedicine, mobile health applications, and wearable gadgets that improve healthcare provision, patient interaction, and health management. For example, AstraZeneca PLC, a British biopharmaceutical firm, presented Evinova in November 2023, an innovative health-tech venture committed to promoting progress in the life sciences domain and enhancing the execution of clinical trials. With an emphasis on bettering health results, it intends to provide digital products and services, tried and tested in AstraZeneca’s clinical trials across over 40 nations, at a global scale. Evinova’s focus on refining clinical trial design and execution aims to simplify the development process of new drugs, consequently lowering both time and expenses.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-outsourcing-global-market-report
Which Countries Are Leading the Drug Discovery Outsourcing Market?
North America was the largest region in the drug discovery outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19405
This Report Delivers Insight On:
1. How big is the drug discovery outsourcing market, and how is it changing globally?
2. Who are the major companies in the drug discovery outsourcing market, and how are they performing?
3. What are the key opportunities and risks in the drug discovery outsourcing market right now?
4. Which products or customer segments are growing the most in the drug discovery outsourcing market?
5. What factors are helping or slowing down the growth of the drug discovery outsourcing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model